Skip to content

Effect of the Increase of daily steps in Urinary symptoms and Cardiac function in men aged 50 to 59 years

Effect of the Increase of daily steps in Lower urinary tract symptoms, Autonomic cardiac function and Maximum oxygen consupmtion in men aged 50 to 59 years

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4vynk5
Enrollment
Unknown
Registered
2020-08-07
Start date
2016-07-27
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Men with lower urinary tract symptoms

Interventions

The sample was calculated in 38 patients randomically divided in two groups: Intervention and Control. After the recruitment, the patients were initially evaluated at their home, considering the porta
not to ingest alcohol and not to perform vigorous physical activity twenty-four hours before the assessment, and then submitted to the following evaluations: a) LUTS presence through the IPSS question
and d) Flexibility was evaluates through the Seat and Reach test with Wells Sanny® bench with an accuracy of 0.5 centimeters. The sample will be splited into two groups. The control group will recei
Procedure/surgery
G11.427.410.698.277

Sponsors

Hospital Universitàrio da Faculdade de Medicina da Universidade Federal de Juiz de Fora
Lead Sponsor
Hospital Universitàrio da Faculdade de Medicina da Universidade Federal de Juiz de Fora
Collaborator

Eligibility

Sex/Gender
Male
Age
50 Years to 59 Years

Inclusion criteria

Inclusion criteria: men, aged 50 to 59 years, complain of lower urinary tract symptoms with a result greater than or equal to eight in the application of the International Prostate Symptom Score instrument

Exclusion criteria

Exclusion criteria: Tobacco use, conditions that make physical exercise unfeasible, chronic or prostatic diseases, previous history of bladder or prostatic surgery, neurological dysfunction of the bladder, bladder neck or urethral stenosis, as well as lithiasis, carcinoma or bladder polyposis, recurrent UTI, concomitant use or in the month prior to inclusion of any drug or condition affecting urinary function, cardiological and neurological diseases and use of any drug or substance that had action in the autonomic nervous system.

Design outcomes

Primary

MeasureTime frame
Expected endpoint: The primary endpoint with respect to the effect of the pedometer use was the increase of number of steps per day after 12 weeks of intervention. Based on an expected increase of 1250 steps per day with a standard deviation of 1400 steps and adopting a 95% confidence interval, alpha error of 0.05, study power of 80% and a two-tailed hypothesis, a total of 38 men were required. ;Endpoint found: After an intervention period of 12 weeks, regarding the primary endpoint, to reach the goal of 10,000 steps daily, the intervention group that made use of the pedometer obtained better results. The number of steps per day in the intervention group was 9753 ± 1549 compared to 6212 ± 1152, p < 0,001

Secondary

MeasureTime frame
Expected endpoint: Improvement of lower urinary tract symptoms through decrease in international prostatic symptoms (IPSS) score ;Endpoint found: Regarding the IPSS score, the intervention group achieved lower scores than the control groups (6.95 ± 2.85 vs 10.16 ± 3.23, p<0,001) ;Expected endpoint: Improvements of cardiorespiratory fitness though indirect maximum oxygen cunsumption measurement;Endpint found: In the analysis of the cardiorespiratory fitness evaluated through the indirect measure of maximum oxygen consumption, the intervention group performed better than the control group (34.84 ± 3.25 vs 32.58 ± 6.89, p=0,011). ;Expected endpoint: Improvement of anthropometric measures though abdomen circumference, body mass index and hip and hip waist ratio;Endpoint found: there was no difference in anthropometric values between the groups;Expected endpoint: Improvement of flexibility measures ;Endpoint found: there was no difference in flexibility values between the groups

Countries

Brazil

Contacts

Public ContactAndré Figueiredo

Hospital Universitàrio da Faculdade de Medicina da Universidade Federal de Juiz de Fora

andreavaresef@gmail.com+55-32-988551973

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 21, 2026